Cargando…
DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732789/ https://www.ncbi.nlm.nih.gov/pubmed/36474349 http://dx.doi.org/10.1177/10760296221144044 |
| _version_ | 1784846215300513792 |
|---|---|
| author | Ryu, Rachel |
| author_facet | Ryu, Rachel |
| author_sort | Ryu, Rachel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9732789 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97327892022-12-10 DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) Ryu, Rachel Clin Appl Thromb Hemost Letter to the Editor SAGE Publications 2022-12-06 /pmc/articles/PMC9732789/ /pubmed/36474349 http://dx.doi.org/10.1177/10760296221144044 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Ryu, Rachel DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa (Apixaban) and INVICTUS (Rivaroxaban) |
| title | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa
(Apixaban) and INVICTUS (Rivaroxaban) |
| title_full | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa
(Apixaban) and INVICTUS (Rivaroxaban) |
| title_fullStr | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa
(Apixaban) and INVICTUS (Rivaroxaban) |
| title_full_unstemmed | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa
(Apixaban) and INVICTUS (Rivaroxaban) |
| title_short | DOACs in Valvular Heart Disease: Latest Key Updates on PROACT Xa
(Apixaban) and INVICTUS (Rivaroxaban) |
| title_sort | doacs in valvular heart disease: latest key updates on proact xa
(apixaban) and invictus (rivaroxaban) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732789/ https://www.ncbi.nlm.nih.gov/pubmed/36474349 http://dx.doi.org/10.1177/10760296221144044 |
| work_keys_str_mv | AT ryurachel doacsinvalvularheartdiseaselatestkeyupdatesonproactxaapixabanandinvictusrivaroxaban |